Moderna, Inc. — Director's Dealing 2023

Feb 3, 2023

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2022-12-31

Reporting Person: LANGER ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-05	Common Stock	G	703	—	Disposed	11466961	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14132	Indirect
Common Stock	14132	Indirect
Common Stock	14132	Indirect

Footnotes

F1: The reported disposition represents a bona fide charitable gift made by the reporting person.